Business Description
Enzon Pharmaceuticals Inc
NAICS : 325414
SIC : 2836
ISIN : US2939041081
Description
Enzon Pharmaceuticals Inc is positioned as a public company acquisition vehicle, where the Company can become an acquisition platform and more fully utilize its net operating loss carryforwards and enhance stockholder value.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.07 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | -0.66 | |||||
| Beneish M-Score | -2.11 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 18.6 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 56.09 | |||||
| 9-Day RSI | 51.21 | |||||
| 14-Day RSI | 50.07 | |||||
| 6-1 Month Momentum % | 157.45 | |||||
| 12-1 Month Momentum % | -11.74 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 113.75 | |||||
| Quick Ratio | 113.75 | |||||
| Cash Ratio | 112.75 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -4200 | |||||
| Net Margin % | 6111.54 | |||||
| FCF Margin % | 5280.77 | |||||
| ROE % | 52.69 | |||||
| ROA % | 3.38 | |||||
| ROIC % | -433.32 | |||||
| 3-Year ROIIC % | 37.59 | |||||
| ROCE % | -2.36 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 76.25 | |||||
| PE Ratio without NRI | 76.25 | |||||
| Shiller PE Ratio | 1.27 | |||||
| PB Ratio | 3.81 | |||||
| Price-to-Tangible-Book | 3.81 | |||||
| Price-to-Free-Cash-Flow | 8.48 | |||||
| Price-to-Operating-Cash-Flow | 8.48 | |||||
| EV-to-EBIT | 32.21 | |||||
| EV-to-EBITDA | 32.21 | |||||
| EV-to-Revenue | -1352.73 | |||||
| EV-to-FCF | -25.8 | |||||
| Price-to-Projected-FCF | 0.95 | |||||
| Price-to-Graham-Number | 3.81 | |||||
| Price-to-Net-Current-Asset-Value | 3.81 | |||||
| Price-to-Net-Cash | 5.08 | |||||
| Earnings Yield (Greenblatt) % | 3.1 | |||||
| FCF Yield % | 12.13 | |||||
| Forward Rate of Return (Yacktman) % | 197.52 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:ENZN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Enzon Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.026 | ||
| EPS (TTM) ($) | 0.002 | ||
| Beta | 0.39 | ||
| Volatility % | 99.71 | ||
| 14-Day RSI | 50.07 | ||
| 14-Day ATR ($) | 0.01127 | ||
| 20-Day SMA ($) | 0.152368 | ||
| 12-1 Month Momentum % | -11.74 | ||
| 52-Week Range ($) | 0.06 - 0.24 | ||
| Shares Outstanding (Mil) | 74.21 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Enzon Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Enzon Pharmaceuticals Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Enzon Pharmaceuticals Inc Frequently Asked Questions
What is Enzon Pharmaceuticals Inc(ENZN)'s stock price today?
The current price of ENZN is $0.15. The 52 week high of ENZN is $0.24 and 52 week low is $0.06.
When is next earnings date of Enzon Pharmaceuticals Inc(ENZN)?
The next earnings date of Enzon Pharmaceuticals Inc(ENZN) is 2024-11-08 Est..
Does Enzon Pharmaceuticals Inc(ENZN) pay dividends? If so, how much?
Enzon Pharmaceuticals Inc(ENZN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers